• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性咳嗽中的κ和μ阿片受体:当前证据与未来治疗

Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment.

作者信息

Birring Surinder S, Dicpinigaitis Peter V, Maher Toby M, Mazzone Stuart B, Page Clive P, Hawi Amale, Sciascia Thomas, Morice Alyn H

机构信息

Centre for Human & Applied Physiological Sciences, School of Basic & Medical Biosciences, King's College London, London, UK.

Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.

出版信息

Lung. 2025 May 13;203(1):62. doi: 10.1007/s00408-025-00812-8.

DOI:10.1007/s00408-025-00812-8
PMID:40358749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075272/
Abstract

Chronic cough is a significant burden on patient quality of life and is associated with poor health outcomes. Chronic cough may be a result of neural hypersensitivity due to changes in both the peripheral and the central nervous systems, although the exact mechanisms underlying its pathogenesis are not completely understood. Opioid receptors, specifically kappa and mu, are potential therapeutic targets in the management of chronic cough because they play a pivotal role in both the peripheral and the central neural pathways implicated in the act of coughing. Morphine, a mu opioid receptor agonist, is an effective cough modulator; however, mu receptor agonists are part of a drug class that can induce respiratory depression and euphoria, with strong reinforcing properties that may lead to excessive use and abuse. Drugs with a dual-acting mechanism of kappa receptor agonism and mu receptor antagonism may be effective in the management of chronic cough without the potential for abuse. This review summarizes the current understanding of the mechanisms of cough hypersensitivity, the role of the kappa and mu receptors in the neurophysiology of cough, and the clinical potential of targeting these receptors as a novel way of managing chronic cough.

摘要

慢性咳嗽对患者生活质量造成重大负担,并与不良健康后果相关。慢性咳嗽可能是外周和中枢神经系统变化导致神经超敏反应的结果,尽管其发病的确切机制尚未完全明确。阿片受体,特别是κ和μ受体,是慢性咳嗽治疗中的潜在靶点,因为它们在咳嗽行为涉及的外周和中枢神经通路中均起关键作用。吗啡作为一种μ阿片受体激动剂,是一种有效的咳嗽调节剂;然而,μ受体激动剂属于一类可导致呼吸抑制和欣快感的药物,具有很强的强化特性,可能导致过度使用和滥用。具有κ受体激动和μ受体拮抗双重作用机制的药物可能对慢性咳嗽的治疗有效且无滥用风险。本综述总结了目前对咳嗽超敏反应机制、κ和μ受体在咳嗽神经生理学中的作用以及将这些受体作为治疗慢性咳嗽新方法的临床潜力的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9162/12075272/c10e73043ddd/408_2025_812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9162/12075272/c10e73043ddd/408_2025_812_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9162/12075272/c10e73043ddd/408_2025_812_Fig1_HTML.jpg

相似文献

1
Kappa and Mu Opioid Receptors in Chronic Cough: Current Evidence and Future Treatment.慢性咳嗽中的κ和μ阿片受体:当前证据与未来治疗
Lung. 2025 May 13;203(1):62. doi: 10.1007/s00408-025-00812-8.
2
Current and emerging opioids for the treatment of chronic cough: a mini review.用于治疗慢性咳嗽的现有和新兴阿片类药物:小型综述。
Expert Opin Pharmacother. 2024 Nov;25(16):2167-2175. doi: 10.1080/14656566.2024.2418983. Epub 2024 Oct 24.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.κ 型和 μ 型阿片受体激动剂之间的相互作用:混合物中药物比例的影响。
Psychopharmacology (Berl). 2018 Aug;235(8):2245-2256. doi: 10.1007/s00213-018-4920-x. Epub 2018 May 22.
5
Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.κ/μ混合型部分阿片受体激动剂作为可卡因依赖的潜在治疗方法。
Adv Pharmacol. 2014;69:387-418. doi: 10.1016/B978-0-12-420118-7.00010-X.
6
Role of opioidergic and serotonergic mechanisms in cough and antitussives.阿片能和5-羟色胺能机制在咳嗽及镇咳药中的作用
Pulm Pharmacol. 1996 Oct-Dec;9(5-6):349-56. doi: 10.1006/pulp.1996.0046.
7
Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.全身给予μ、δ和κ阿片受体亚型激动剂和拮抗剂对小鼠体温的功能影响。
J Pharmacol Exp Ther. 2002 Sep;302(3):1253-64. doi: 10.1124/jpet.102.037655.
8
The antitussive effects of endomorphin-1 and endomorphin-2 in mice.内吗啡肽-1和内吗啡肽-2对小鼠的镇咳作用。
Eur J Pharmacol. 2003 Apr 25;467(1-3):219-22. doi: 10.1016/s0014-2999(03)01634-0.
9
Biased Opioid Ligands.偏性阿片类配体。
Molecules. 2020 Sep 16;25(18):4257. doi: 10.3390/molecules25184257.
10
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.BU74,一种具有强效κ阿片受体激动作用和延迟阿片拮抗作用的复杂阿片碱衍生物。
Eur J Pharmacol. 2005 Feb 21;509(2-3):117-25. doi: 10.1016/j.ejphar.2004.12.035.

本文引用的文献

1
Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study.难治性或不明原因慢性咳嗽患者中可待因治疗反应者的特征:一项前瞻性真实世界队列研究。
Lung. 2024 Apr;202(2):97-106. doi: 10.1007/s00408-024-00674-6. Epub 2024 Feb 27.
2
Nalbuphine Tablets for Cough in Patients with Idiopathic Pulmonary Fibrosis.纳布啡片治疗特发性肺纤维化患者的咳嗽。
NEJM Evid. 2023 Aug;2(8):EVIDoa2300083. doi: 10.1056/EVIDoa2300083. Epub 2023 May 22.
3
Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.
吗啡治疗特发性肺纤维化咳嗽(PACIFY咳嗽):一项前瞻性、多中心、随机、双盲、安慰剂对照、双向交叉试验。
Lancet Respir Med. 2024 Apr;12(4):273-280. doi: 10.1016/S2213-2600(23)00432-0. Epub 2024 Jan 15.
4
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.一项关于κ阿片受体及其配体的系统评价:用于治疗疼痛、焦虑、抑郁和药物滥用的新方向。
Eur J Med Chem. 2022 Dec 5;243:114785. doi: 10.1016/j.ejmech.2022.114785. Epub 2022 Sep 22.
5
Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.κ-阿片受体和μ-阿片受体在瘙痒中的作用:外周和中枢瘙痒回路。
Exp Dermatol. 2022 Dec;31(12):1900-1907. doi: 10.1111/exd.14669. Epub 2022 Sep 23.
6
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.κ阿片受体:多种病症的一个有前景的治疗靶点。
Front Pharmacol. 2022 Jun 20;13:837671. doi: 10.3389/fphar.2022.837671. eCollection 2022.
7
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain.阿片受体介导的大脑神经传递调节
Front Mol Neurosci. 2022 Jun 15;15:919773. doi: 10.3389/fnmol.2022.919773. eCollection 2022.
8
Cough hypersensitivity and chronic cough.咳嗽敏感性和慢性咳嗽。
Nat Rev Dis Primers. 2022 Jun 30;8(1):45. doi: 10.1038/s41572-022-00370-w.
9
ATP, an attractive target for the treatment of refractory chronic cough.三磷酸腺苷,难治性慢性咳嗽治疗的一个有吸引力的靶点。
Purinergic Signal. 2022 Sep;18(3):289-305. doi: 10.1007/s11302-022-09877-z. Epub 2022 Jun 21.
10
Prevalence of chronic cough and patient characteristics in adults in Spain: A population-based cross-sectional survey.慢性咳嗽在西班牙成年人中的流行情况及患者特征:一项基于人群的横断面调查。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221098722. doi: 10.1177/14799731221098722.